These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 9038062

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Assessment of cerebral benzodiazepine receptor distribution in epilepsy by 123I-iomazenil-SPECT].
    Uchiyama M, Sue H, Fukumitsu N, Mori Y, Kawakami K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jan; 57(1):47-51. PubMed ID: 9038063
    [Abstract] [Full Text] [Related]

  • 3. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
    Kitamura S, Koshi Y, Komiyama T, Sakayori O, Komaba Y, Ohyama M, Mishina M, Tsuganesawa T, Terashi A.
    Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation of benzodiazepine receptor in the cerebral cortex of Parkinson's disease using 123I-iomazenil SPECT].
    Kawabata K, Tachibana H.
    Nihon Rinsho; 1997 Jan; 55(1):244-8. PubMed ID: 9014458
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders].
    Torizuka K, Uemura K, Toru M, Shinohara Y, Nishimura T, Yonekura Y, Nakagawara J, Matsuda H, Sakai F, Matsuda K, Fukuyama H, Morimoto K.
    Kaku Igaku; 1996 Mar; 33(3):303-18. PubMed ID: 8622264
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantitative estimation of I-123-Iomazenil receptor binding in temporal lobe epilepsies using two SPECT acquisitions--comparison with the regional cerebral blood flow and a compartment model.
    Venz S, Hierholzer J, Cordes M, Straub HB, Keske U, Meencke HJ, Eichstädt H, Felix R.
    Nuklearmedizin; 1998 Mar; 37(2):49-56. PubMed ID: 9547750
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT].
    Yonekura Y, Nishizawa S, Tanaka F, Ishizu K, Okazawa H, Fujita T, Konishi J, Torizuka K.
    Kaku Igaku; 1995 Jan; 32(1):87-97. PubMed ID: 7897872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.